Evolus, Inc.

NASDAQ:EOLS

Drug Manufacturers - Specialty & Generic

Healthcare
$7.07 -2.00%

-$0.14 today

Market cap
$467.95M
Beta
1.33
P/E (TTM)
-9.9
EPS (TTM)
-$0.67
52W Low $3.86High $10.20

Volume 0.80M

Average 0.86M

EOLS Long-term Debt

Borrowings due after more than one year.

Evolus, Inc.NASDAQ: EOLS

Long-term Debt · Q1 FY2026 · quarter ended Mar 2026

Long-term debt rises 28.4% from a year ago

Long-term debt stood at $156.41M at the end of Q1 FY2026, up 28.4% from a year earlier and up 7.1% from the prior quarter. Over 3 fiscal years it compounded at +26.7% a year.

Context

  • Long-term debt amounted to 70.9% of total assets at the end of Q1 FY2026, up 13.8 pp from a year earlier.
  • Long-term debt increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether long-term debt keeps rising in the next quarterly balance sheet after a +28.4% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$156.41M+7.1% QoQ
Last fiscal yearDec 2025
$146.1M+20.2% YoY
Year agoMar 2025
$121.81M+28.4% since
Long-term Debt past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+28.4%——
1 year+20.2%——
3-year CAGR+26.7%——
5-year CAGR——
10-year CAGR——

Long-term Debt history

USD · from the balance sheet

Latest · FY2025
146.1M USD
Year-over-year change
+20.2%
4-year CAGR
+19.7%

Long-term Debt vs competitors

How EOLS compares with its peers on the latest reported figures

No competitor Long-term Debt figures are available to compare.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents146.26M53.92M62.84M86.95M53.83M
Short-term Investments00000
Net Receivables14.66M22.45M30.53M47.68M54.7M
Inventory1.76M18.85M11M12.16M26.96M
Other Current Assets11.04M1.68M2.36M1.2M3.67M
Total Current Assets178.8M100.8M112.42M151.34M142.92M
Property, Plant & Equipment (Net)4.09M4.56M7.85M10.41M12.5M
Goodwill21.21M21.21M21.21M21.21M21.21M
Intangible Assets50.63M48.6M47.11M48.75M48.04M
Long-term Investments00000
Tax Assets00000
Other Non-current Assets2.76M2.81M409K858K1.2M
Total Non-current Assets78.68M77.18M76.58M81.23M82.95M
Total Assets257.48M177.98M189M232.57M225.87M
Account Payables6.09M8.94M4.27M9.24M23.36M
Short-term Debt00000
Tax Payables00000
Deferred Revenue7.93M9.01M11.03M14.45M11.55M
Other Current Liabilities0018.18M01.3M
Total Current Liabilities57.66M46.51M48.29M62.96M75.31M
Long-term Debt71.22M71.88M120.36M121.51M146.1M
Deferred Tax Liabilities40K22K27K6K28K
Deferred Revenue (Non-current)00000
Other Non-current Liabilities44.43M39.85M36.2M35.82M21.17M
Total Non-current Liabilities117.94M112.98M161.4M164.09M173.67M
Total Liabilities175.61M159.48M209.69M227.05M248.97M
Common Stock1K1K1K1K1K
Retained Earnings(422.88M)(497.29M)(558.98M)(609.4M)(661.04M)
Accumulated OCI0(337K)(427K)(905K)(156K)
Other Stockholders Equity00000
Minority Interest00000
Total Equity81.88M18.5M(20.69M)5.52M(23.11M)
Total Debt74.74M74.42M126.55M129.98M155M
Net Debt(71.51M)20.5M63.71M43.03M101.17M

Evolus, Inc.

NASDAQ:EOLS

Intrinsic Alpha fair value

Locked

Current Price

$7.07

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.